×

PHARMACEUTICAL FORMULATIONS OF A BRUTON'S TYROSINE KINASE INHIBITOR

  • US 20200237673A1
  • Filed: 04/10/2020
  • Published: 07/30/2020
  • Est. Priority Date: 03/03/2015
  • Status: Active Grant
First Claim
Patent Images

1. A solid tablet formulation comprising ibrutinib and pharmaceutically acceptable excipients, wherein the ibrutinib is a compound with the structure of Compound 1,

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×